PROBUPHINE

Dead / Cancelled — Cancelled — Section 8 (as of 06 Oct 2023)

What this means for you

This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
85867659
Registration number
5166633
Mark type
Design + words
Filed
05 Mar 2013
Published for opposition
18 Jun 2013
Registered
21 Mar 2017
Attorney of record
Muzamil Huq

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and lifethreatening diseases

Owner

Prior registrations

Prosecution history

  • 12 Jan 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
  • 12 Jan 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 12 Jan 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 12 Jan 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 12 Jan 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 12 Jan 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 06 Oct 2023 — CANCELLED SEC. 8 (6-YR)
  • 21 Mar 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 26 Dec 2018 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 26 Dec 2018 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 21 Mar 2017 — REGISTERED-PRINCIPAL REGISTER
  • 14 Feb 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 12 Feb 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 08 Feb 2017 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 08 Feb 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE

View this trademark record on Marksy